Combined neoadjuvant weekly paclitaxel and trastuzumab for HER2-overexpressing breast cancer

被引：0
|
作者：
Horiguchi, J. [1 ]
Koibuchi, Y. [1 ]
Rokutanda, N. [1 ]
Nagaoka, R. [1 ]
Kikuchi, M. [1 ]
Sato, A. [1 ]
Ishikawa, Y. [1 ]
Odawara, H. [1 ]
Iino, Y. [1 ]
Takeyoshi, I. [1 ]
机构：
[1] Gunma Univ Hosp, Maebashi, Gunma, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3045
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Effects of trastuzumab and paclitaxel in HER2-overexpressing breast cancer
    Li, Songhua
    Higuchi, Hideo
    Ohuchi, Noriaki
    FUTURE MEDICAL ENGINEERING BASED ON BIONANOTECHNOLOGY, PROCEEDINGS, 2006, : 395 - +
  • [2] Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer
    Clara Natoli
    Patrizia Vici
    Isabella Sperduti
    Antonino Grassadonia
    Giancarlo Bisagni
    Nicola Tinari
    Andrea Michelotti
    Germano Zampa
    Stefania Gori
    Luca Moscetti
    Michele De Tursi
    Michele Panebianco
    Maria Mauri
    Ilaria Ferrarini
    Laura Pizzuti
    Corrado Ficorella
    Riccardo Samaritani
    Lucia Mentuccia
    Stefano Iacobelli
    Teresa Gamucci
    Journal of Cancer Research and Clinical Oncology, 2013, 139 : 1229 - 1240
  • [3] Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer
    Natoli, Clara
    Vici, Patrizia
    Sperduti, Isabella
    Grassadonia, Antonino
    Bisagni, Giancarlo
    Tinari, Nicola
    Michelotti, Andrea
    Zampa, Germano
    Gori, Stefania
    Moscetti, Luca
    De Tursi, Michele
    Panebianco, Michele
    Mauri, Maria
    Ferrarini, Ilaria
    Pizzuti, Laura
    Ficorella, Corrado
    Samaritani, Riccardo
    Mentuccia, Lucia
    Iacobelli, Stefano
    Gamucci, Teresa
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (07) : 1229 - 1240
  • [4] Weekly Gemcitabine and Trastuzumab in the Treatment of Patients With HER2-Overexpressing Metastatic Breast Cancer
    Yardley, Denise A.
    Burris, Howard A., III
    Hanson, Sarah
    Greco, F. Anthony
    Spigel, David R.
    Barton, John
    Hainsworth, John D.
    CLINICAL BREAST CANCER, 2009, 9 (03) : 178 - 183
  • [5] Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC)
    Datko, Farrah Mikhail
    D'Andrea, Gabriella
    Dickler, Maura N.
    Theodoulou, Maria
    Goldfarb, Shari Beth
    Lake, Diana
    Fornier, Monica Nancy
    Modi, Shanu
    Sklarin, Nancy T.
    Comen, Elizabeth Anne
    Fasano, Julie
    Gajria, Devika
    Drullinsky, Pamela
    Murphy, Conleth G.
    Syldor, Angemael
    Patil, Sujata
    Liu, Jennifer
    Chandarlapaty, Sarat
    Hudis, Clifford
    Dang, Chau T.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)
  • [6] Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC).
    Datko, Farrah Mikhail
    D'Andrea, Gabriella
    Dickler, Maura N.
    Goldfarb, Shari Beth
    Theodoulou, Maria
    Lake, Diana
    Fornier, Monica Nancy
    Modi, Shanu
    Fasano, Julie
    Comen, Elizabeth Anne
    Gajria, Devika
    Moynahan, Mary Ellen
    Traina, Tiffany A.
    Chen, Melanie
    Hamilton, Nicola
    Patil, Sujata
    Chandarlapaty, Sarat
    Hudis, Clifford
    Dang, Chau T.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [7] Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with metastatic HER2-overexpressing metastatic breast cancer
    Datko, F.
    D'Andrea, G.
    Dickler, M.
    Theodoulou, M.
    Goldfarb, S.
    Lake, D.
    Fornier, M.
    Modi, S.
    Sklarin, N.
    Comen, E.
    Fasano, J.
    Gajria, D.
    Drullinsky, P.
    Gilewski, T.
    Murphy, C.
    Syldor, A.
    Lau, A.
    Hamilton, N.
    Patil, S.
    Liu, J.
    Chandarlapaty, S.
    Hudis, C.
    Dang, C.
    CANCER RESEARCH, 2012, 72
  • [8] A phase II study of three-weekly docetaxel and weekly trastuzumab in HER2-overexpressing advanced breast cancer
    Montemurro, F
    Choa, G
    Faggiuolo, R
    Donadio, M
    Minischetti, M
    Durando, A
    Capaldi, A
    Vietti-Ramus, G
    Alabiso, O
    Aglietta, M
    ONCOLOGY, 2004, 66 (01) : 38 - 45
  • [9] Mechanisms of resistance to trastuzumab as neoadjuvant therapy in women with HER2-overexpressing operable breast cancer.
    Jinno, Hiromitsu
    Sato, Tomomi
    Hayashida, Tetsu
    Takahashi, Maiko
    Hirose, Shigemichi
    Kitagawa, Yuko
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [10] Phase II study of weekly paclitaxel and trastuzumab in anthracycline- and taxane-pretreated patients with HER2-overexpressing metastatic breast cancer
    S Gori
    M Colozza
    A M Mosconi
    E Franceschi
    C Basurto
    R Cherubini
    A Sidoni
    A Rulli
    C Bisacci
    V De Angelis
    L Crinò
    M Tonato
    British Journal of Cancer, 2004, 90 : 36 - 40
12345